Patient Example. by James M. Friedman (22522150)

Subjects:

Spontaneous oxycodone withdrawal transiently eliminates diurnal changes in NREM depth. by Michael Gulledge (20577135)

Subjects:

Definitions of the key terms used in this study. by Eriko Takahashi (22608061)

Subjects:

Spontaneous oxycodone withdrawal disrupts sleep/wake architecture. by Michael Gulledge (20577135)

Subjects:

Recruitment flow diagram of the current study. by Somayeh Momenyan (10111603)

“…Phase 1 EQ-VAS decreases were associated with female sex, lower somatic symptom, fewer comorbidities, lack of expectation for a fast recovery, higher ISS, higher injury pain, neck, spine/back or lower extremity injuries. …”

Results from Ordinary Least Squares (OLS). by Muhummad Khairul Islam (21955544)

Subjects:

Correlation Matrix. by Muhummad Khairul Islam (21955544)

Subjects:

Multicollinearity Test. by Muhummad Khairul Islam (21955544)

Subjects:

Descriptive Statistics. by Muhummad Khairul Islam (21955544)

Subjects:

Metabolic and molecular effects of high-fat diet (HFD). by Ping-yu Cai (12389929)

Subjects:

Characteristics of water footprint by sector at the regional level in China. by Jianqin Ma (20328414)

Subjects:

miR-150-5p inhibition modulates pyroptosis and FoxO3a/ARC signaling in ApoE^-/- mice. by Ping-yu Cai (12389929)

Subjects:

Therapeutic effects of miR-150-5p inhibition on ox-LDL-induced pyroptosis in RAW264.7 macrophages. by Ping-yu Cai (12389929)

Subjects:

Therapeutic effects of miR-150-5p inhibition on atherosclerotic lesion development. by Ping-yu Cai (12389929)

Subjects:

Dysregulation of miR-150-5p and its target FoxO3a in atherosclerosis (AS). by Ping-yu Cai (12389929)

Subjects:

Demographic information. by Silas Manning (22693338)

Subjects:

S1 File - by Michael Gulledge (20577135)

Subjects:

SHAP dependence plots with interaction coloring. by Wentao Yang (205781)

Subjects:

Screening process diagram. by Wentao Yang (205781)

Subjects:

SHAP waterfall plot. by Wentao Yang (205781)

Subjects: